Anionic bacterial membrane lipids

Anionic bacterial membrane lipids are essential structural components of the bacterial cell envelope that impart a net negative charge to the cell surface (Epand et al., 2016, Biochimica et Biophysica Acta). In Gram-positive bacteria, these lipids primarily include phosphatidylglycerol and cardiolipin, whereas Gram-negative bacteria also possess lipopolysaccharide (LPS) in their outer membrane (Poirel et al., 2017, Clinical Microbiology Reviews). This anionic characteristic is a primary differentiator from mammalian cell membranes, which are largely composed of zwitterionic lipids like phosphatidylcholine (Muller et al., 2016, Nature Communications). Therapeutic agents such as polymyxins and daptomycin exploit this charge difference to selectively bind to and disrupt the bacterial membrane (Li et al., 2017, Lancet Infectious Diseases). This interaction typically leads to membrane depolarization, the formation of lethal pores, or the inhibition of cell wall precursors, resulting in rapid bactericidal activity (Silver, 2011, Clinical Microbiology Reviews). Because these lipids are vital for membrane integrity and are less susceptible to rapid mutational changes than protein targets, they are highly valued in the development of treatments for multi-drug resistant infections (Hurdle et al., 2011, Nature Reviews Microbiology).

Other names

Bacterial anionic lipidsNegatively charged bacterial lipidsPhosphatidylglycerolCardiolipinLipopolysaccharideLipoteichoic acid

Drugs targeting anionic bacterial membrane lipids typically utilize electrostatic interactions to bind to the negatively charged surface, leading to membrane depolarization, pore formation, and physical disruption of the lipid bilayer, which results in the leakage of essential intracellular ions and cell death.